Access cutting-edge recurrent urinary tract infection treatment through this clinical trial at a research site in Brooklyn. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Brooklyn location
Preparing your pre-screening questions…
Access recurrent urinary tract infection specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related recurrent urinary tract infection treatment provided free
Check if you qualify for this recurrent urinary tract infection clinical trial in Brooklyn, NY
No-Cost Study Care
Local to Brooklyn
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Women over the age of 60 years have an estimated 10 to 15 % risk of recurrent urinary tract infections (UTI). This is believed to be due to hormonally induced changes in the vaginal flora associated with menopause. After menopause, there is a chemical changes in the vagina that may predispose to bacterial infections. The role of vaginal estrogen creams to restore vaginal atrophy and prevent urinary tract infections has been well characterized. Vaginal testosterone (VT) application use in postmenopausal breast cancer patients on aromatase inhibitors have been shown to improve vaginal pH, vaginal atrophy symptom scores, dyspareunia, and vaginal dryness. Although testosterone has been used to improve sexual function in postmenopausal women, the effects of VT on vaginal flora and recurrent UTIs are unknown. The purpose of this study is to determine whether topically applied vaginal testosterone cream is more effective than placebo in reducing the incidence of urinary tract infections in postmenopausal women with recurrent urinary tract infections and to ascertain the effects of topical estrogen on the vaginal pH and flora.
Sponsor: Maimonides Medical Center
Yes, this clinical trial (NCT04807894) has an active research site in Brooklyn, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for recurrent urinary tract infection treatment options in Brooklyn, NY, this clinical trial (NCT04807894) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Brooklyn research site is actively enrolling participants for this clinical trial. You'll receive care from experienced recurrent urinary tract infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all recurrent urinary tract infection clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Brooklyn — not just this study.
Browse Rheumatoid Arthritis Trials in Brooklyn →